Faculty & Research

Faculty Profiles

Faculty Research Projects

Research Centers & Initiatives

Resources for Faculty

Faculty & Staff Directory

HIPAA

A. Fendrick

A. Mark Fendrick, M.D.

Professor, Division of General Medicine, Department of Internal Medicine and Department of Health Management and Policy

Co-Director, Consortium for Health Outcomes Innovation and Cost Effectiveness Studies (CHOICES)


Director, Health Services Research Core Lab

300 NIB, 7E06
Ann Arbor, Michigan 48109-0429

Office: (734) 647-9688; Fax: (734) 936-8944

E-mail: amfen@umich.edu

Website(s): Consortium for Health Outcomes Innovation and Cost Effectiveness Studies (CHOICES); University of Michigan Center for Value-Based Insurance Design

Curriculum Vitae (PDF, 144,051 KB)

Professional Summary

A. Mark Fendrick, M.D., is a Professor in the Department of Internal Medicine and the Department of Health Management and Policy. Since 1996, he has been Co-Director of the Consortium for Health Outcomes Innovation and Cost Effectiveness Studies (CHOICES), and directs the recently established Health Services Research Core Laboratory.

Dr. Fendrick has authored over 100 articles and book chapters and has given several national and international presentations pertaining to outcomes research and economic evaluation of medical interventions. He has collaborated with several government agencies and professional societies and has consulted for numerous health care companies. Dr. Fendrick currently serves on the board of directors of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is on the editorial board for four peer-reviewed publications. He is the co-editor in chief of The American Journal of Managed Care.

Education

M.D., Harvard Medical School, 1987
B.A. (Summa Cum Laude), Economics/Chemistry, University of Pennsylvania, 1982

Research Interest & Projects

Dr. Fendrick's research focuses on the clinical and economic assessment of medical interventions with special attention to the study of emerging technologies. He has performed economic analyses of new interventions for several common conditions including: laparoscopic cholecystectomy, gastroesophageal reflux disease, arthritis/inflammatory conditions, viral infections, acute myocardial infarction, pediatric vaccinations, and cancer screening. These analyses are supplemented by research describing how outcomes research data can be incorporated into clinical practice.

Selected Publications

Chernew, M., Smith, D.G., Kirking, D.M., and Fendrick, A.M. (2001). Decomposing Pharmaceutical Cost Growth in Different Types of Health Plans.

Fendrick, A.M., Smith, D.G., Chernew, M.E., et al. (2001). A Benefit-Based Copay for Prescription Drugs: Patient Contribution Based on Total Benefits, Not Drug Acquisition Cost. American Journal of Managed Care, 7, 861-867.

Ladabaum, U., Chopra, C.L., Huang, G., Chernew, M.E., Scheiman, J.M., Fendrick, A.M. (2001). Aspirin as an adjunct to screening for Prevention of Sporadic Colorectal Cancer: A cost-effectiveness Analysis. Journal of General Internal Medicine, 135, 769-781.

Axelrod, D.A., Fendrick, A.M., Wennberg, D.E., et al. (2001). Cardiologists Performing Peripheral Angioplasties: Impact on Utilization. Effective Clinical Practice, 4(5), 191-98.

Langa, K., Kabeto, M., Fendrick, A.M., et al. (2001). National Estimates of the quantity and Cost of Informal Caregiving for the Elderly with Dementia. Journal of General Internal Medicine, 16, 770-8.

Professional Affiliations

Society of General Internal Medicine
American College of Physicians
International Society for Technology Assessment in Health Care (Board of Directors 1995-1998)
International Society for Pharmacoeconomics and Outcomes Research (Board of Directors 2000-2002)
University of Michigan Center for Value-Based Insurance Design